Afatinib treatment of a squamous lung cancer after tumor progression of nivolumab

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|9|1|164-166

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.9, Iss.1, 2018-01, pp. : 164-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 175-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased expression of 14‐3‐3 σ, an early event of malignant transformation of respiratory epithelium, also facilitates progression of squamous cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 715-721

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential anti‐cancer effect of curcumin in human lung squamous cell carcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 508-516

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of lung tumor initiation and progression in transgenic mice for Cre‐inducible overexpression of Cul4A gene

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 480-487

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current small cell lung cancer treatment in China

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 233-238

John Wiley & Sons Inc

Access to resources Recommend Favorite